Академический Документы
Профессиональный Документы
Культура Документы
Average time
Number of Frequency Annual hour Hourly wage Cost to
Data collection task per
participants of response burden rate respond
response
There are no Capital Costs to report. DEPARTMENT OF HEALTH AND assistance. The demographic questions
There are no Operating or Maintenance HUMAN SERVICES will allow CIS to better measure the
Costs to report. program’s reach to underserved
National Institutes of Health populations and program impacts on
Request for Comments: Written
comments and/or suggestions from the these populations. The smoking/tobacco
Proposed Collection; Comment
public and affected agencies are invited use questions are necessary as part of
Request; Collection of Demographic
on one or more of the following points: the intake and needs assessment process
and Smoking/Tobacco Use Information
(1) Whether the proposed collection of From NCI Cancer Information Service for smoking cessation clients. The
information is necessary for the proper Clients information collected about clients’
performance of the function of the smoking history, previous quit attempts,
agency, including whether the SUMMARY: In compliance with the and motivations to quit smoking will
information will have practical utility, requirement of section 3506(c)(2)(A) of enable Information Specialists to
(2) the accuracy of the agency’s estimate the Paperwork Reduction Act of 1995, provide effective individualized
for opportunity for public comment on counseling. Consistent with the current
of the burden of the proposed collection
proposed data collection projects, the data collection, the proposed
of information, including the validity of
National Cancer Institute (NCI), the demographic and smoking intake
the methodology and assumptions used,
National Institutes of Health (NIH) will questions will be asked of clients who
(3) ways to enhance the quality, utility
publish periodic summaries of proposed are cancer patients, family members and
and clarity of the information to be
projects to be submitted to the Office of friends of patients, and the general
collected; and (4) ways to minimize the Management and Budget (OMB) for
burden of the collection of information public. Also consistent with the current
review and approval.
on those who are to respond, including data collection, 25% of telephone and
Proposed Collection: Title: Collection
the use of appropriate automated, quitline clients will be sampled for the
of Demographic and Smoking/Tobacco
electronic, mechanical, or other Use Information from NCI Cancer proposed demographic questions. If the
technological collection techniques or Information Service Clients. Type of call is the result of a special promotion,
other forms of information technology. Information Collection Request: 50% of callers will be surveyed. Overall,
Revision of OMB no. 0925–0208 it is estimated that 36% of telephone
FOR FURTHER INFORMATION CONTACT: To
expiration date 11/30/2006. Need and and quitline clients will be sampled for
request more information on the
Use of Information Collection: The the demographic questions for an
proposed project or to obtain a copy of
NCI’s Cancer Information Service (CIS) estimated annual total of 40,700
the data collection plans and
provides accurate and up-to-date cancer telephone clients and 2,400 quitline
instruments, contact Dr. Richard
information to the public through a toll- clients. Also consistent with the current
Troiano, CDR, U.S. Public Health
Service, Risk Factor Monitoring and free telephone number (1–800–4– data collection, the demographic
Methods Branch, Applied Research CANCER) and LiveHelp, an online questions will be asked of 50% of
Program, Division of Cancer Control and instant messaging service. In addition, LiveHelp clients for an estimated annual
CIS provides smoking cessation total of 2,000 online clients. The higher
Population Sciences, National Cancer
assistance through a telephone quitline sampling rate for LiveHelp clients is
Institute, EPN 4005, 6130 Executive
(accessed through 1–800–44U–QUIT or necessary due to the lower response rate
Blvd, MSC 7344, Bethesda, MD 20892–
1–800–QUITNOW). Characterizing CIS among online clients. The proposed
7344, or call non-toll-free number (301)
clients is essential to customer service, smoking intake questions will be asked
435–6822, or FAX your request to (301)
program planning, and promotion. of 100% of quitline clients for an annual
435–3710, or E-mail your request,
Currently CIS conducts a brief survey of total of approximately 6,700 clients. The
including your address, to: a sample of telephone and LiveHelp
troianor@mail.nih.gov. combined total to be surveyed each year
clients at the end of usual service (OMB is approximately 49,400 CIS clients for
Comments Due Date: Comments no. 0925–0208 expiration date 11/30/ a total of 2,478 annual burden hours.
regarding this information collection are 2006); the survey includes three
Frequency of Response: Single time.
best assured of having their full effect if customer service and five demographic
Affected Public: Individuals or
received within 60 days of the date of questions (age, sex, race, ethnicity,
households. Type of Respondents:
this publication. education). This request is to
supplement the current data collection Cancer patients, family members and
Dated: January 11, 2006. friends of cancer patients, and general
activity by adding (1) four demographic
wwhite on PROD1PC65 with NOTICES
Rachelle Ragland-Greene, questions related to income, health public who contact CIS via telephone or
NCI Project Clearance Liaison, National insurance coverage, and regular source online. The annual reporting burden is
Institutes of Health. of health care; and (2) a set of 20 as follows:
[FR Doc. E6–592 Filed 1–19–06; 8:45 am] smoking/tobacco use questions for
BILLING CODE 4167–01–P individuals seeking smoking cessation
VerDate Aug<31>2005 16:16 Jan 19, 2006 Jkt 208001 PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 E:\FR\FM\20JAN1.SGM 20JAN1
3314 Federal Register / Vol. 71, No. 13 / Friday, January 20, 2006 / Notices
The annualized cost to respondents is Dated: January 8, 2006. Boulevard, Suite 325, Rockville, MD
estimated at approximately: $44,827. Rachelle Ragland-Greene, 20852–3804; Telephone: 301–435–4426;
There are no Capital Costs, Operating National Institutes of Health, NCI Project Facsimile: 301–402–0220; e-mail:
Costs, or Maintenance Costs to report. Clearance Liaison. ms482m@nih.gov.
Request for Comments: Written [FR Doc. E6–593 Filed 1–19–06; 8:45 am] SUPPLEMENTARY INFORMATION:
comments and/or suggestions from the BILLING CODE 4167–01–P Osteoarthritis is a chronic, often
public and affected agencies are invited progressive and substantially disabling
on one or more of the following points: condition that becomes more common
DEPARTMENT OF HEALTH AND with advanced age. Osteoarthritis
(1) Whether the proposed collection of HUMAN SERVICES
information is necessary for the proper commonly involves the knees, hands,
hips, neck and back resulting in pain
performance of the function of the National Institutes of Health and limitations of movement.
agency, including whether the Unfortunately clinically available
information will have practical utility; Prospective Grant of Exclusive
tests are neither capable of detecting
(2) The accuracy of the agency’s License: FDA Approvable Human
osteoarthritis early in its development,
estimate of the burden of the proposed Diagnostic for Osteoarthritis
nor sensitive enough to adequately
collection of information, including the AGENCY: National Institutes of Health, assess disease progression. A better
validity of the methodology and Public Health Service, HHS. means of diagnosing early osteoarthritis
assumptions used; (3) Ways to enhance and its progression that can be used to
ACTION: Notice.
the quality, utility, and clarity of the assess the response to therapeutic
information to be collected; and (4) SUMMARY: This is notice, in accordance treatments is needed. The currently
Ways to minimize the burden of the with 35 U.S.C. 209(c)(1) and 37 CFR available laboratory techniques are
collection of information on those who 404.7(a)(1)(i), that the National highly sensitive but either lack
are to respond, including the use of Institutes of Health (NIH), Department specificity or require large volumes of
appropriate automated, electronic, of Health and Human Services, is sample. Rolling Circle Amplification
mechanical, or other technological contemplating the grant of an exclusive (RCA) is a new technology that precisely
collection techniques or other forms of license worldwide to practice the localizes unique signals arising from
information technology. invention embodied in U.S. Patent single reporter molecules. RCA has been
Application Number 60/602,334 filed incorporated into antibody-based
FOR FURTHER INFORMATION CONTACT: To August 18, 2005, entitled ‘‘Biomarkers microarray system protein chips that
request more information on the for Osteoarthritis,’’ to PeptiFarma, Inc., enable testing with high sensitivity and
proposed project or to obtain a copy of having a place of business in San Diego, specificity for hundreds of proteins
the data collection plans and CA 92191. The contemplated exclusive simultaneously, using small sample
instruments, contact Linda Squiers, license may be limited to an FDA volumes.
PhD., Project Officer for Research, approvable human diagnostic for This invention describes a method of
Cancer Information Service Branch, osteoarthritis. The United States of using RCA technology for detecting the
National Cancer Institute, NIH, 6116 America is an assignee of the patent expression of serum proteins that are
Executive Blvd, MSC 8322, Rockville, rights in this invention. perturbed in osteoarthritis patients. The
MD, 20892–8322, or call non-toll-free results of this testing can be used to
DATES: Only written comments and/or identify proteins associated with
number (301) 594–9075 or E-mail your application for a license which is osteoarthritis presence, prediction of
request, including your address, to: received by the NIH Office of osteoarthritis development and
squiersl@mail.nih.gov. Technology Transfer on or before March prognosis, predict response to
Comments Due Date: Comments 21, 2006 will be considered. osteoarthritis treatment and potentially
regarding this information collection are ADDRESSES: Request for a copy of the also identify future anti-osteoarthritic
best assured of having their full effect if patent, inquires, comments, and other drugs.
wwhite on PROD1PC65 with NOTICES
received within 60 days of the date of materials relating to the contemplated The prospective exclusive license will
this publication. license should be directed to: Marlene be royalty-bearing and will comply with
Astor, Technology Licensing Specialist, the terms and conditions of 35 U.S.C.
Office of Technology Transfer, National 209 and 37 CFR 404.7. The prospective
Institutes of Health, 6011 Executive exclusive license may be granted unless,
VerDate Aug<31>2005 16:16 Jan 19, 2006 Jkt 208001 PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 E:\FR\FM\20JAN1.SGM 20JAN1